Literature DB >> 23323541

Bacterial inhibition of inflammatory responses via TLR-independent mechanisms.

Vladimir V Kravchenko1, Gunnar F Kaufmann.   

Abstract

Identification of cellular processes modulated by microbial organisms that undermine and disarm mammalian host defences against bacterial invaders has been the focus of significant biomedical research. In this microreview we will illustrate the role of bacterial N-acyl homoserine lactones (AHL) as a strategy utilized by Gram-negative bacterial pathogens to enable colonization of the host through AHL-mediated inhibition of inflammation induced via innate immune receptor mechanisms. We will also highlight some of the signalling pathways in which the study of AHL-mediated effects on mammalian cells might lead to the discovery of global underlying principles linking inflammation and immunity to many chronic human diseases, including cancer and obesity.
© 2013 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23323541     DOI: 10.1111/cmi.12109

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  9 in total

1.  Pseudomonas aeruginosa quorum-sensing molecule homoserine lactone modulates inflammatory signaling through PERK and eI-F2α.

Authors:  Mark A Grabiner; Zhu Fu; Tara Wu; Kevin C Barry; Christian Schwarzer; Terry E Machen
Journal:  J Immunol       Date:  2014-07-02       Impact factor: 5.422

2.  Small molecule screen yields inhibitors of Pseudomonas homoserine lactone-induced host responses.

Authors:  Cathleen D Valentine; Hua Zhang; Puay-Wah Phuan; Juliane Nguyen; A S Verkman; Peter M Haggie
Journal:  Cell Microbiol       Date:  2013-08-22       Impact factor: 3.715

3.  Interleukin-8, CXCL1, and MicroRNA miR-146a Responses to Probiotic Escherichia coli Nissle 1917 and Enteropathogenic E. coli in Human Intestinal Epithelial T84 and Monocytic THP-1 Cells after Apical or Basolateral Infection.

Authors:  Harshana Sabharwal; Christoph Cichon; Tobias A Ölschläger; Ulrich Sonnenborn; M Alexander Schmidt
Journal:  Infect Immun       Date:  2016-08-19       Impact factor: 3.441

4.  X-box binding protein 1 (XBP1s) is a critical determinant of Pseudomonas aeruginosa homoserine lactone-mediated apoptosis.

Authors:  Cathleen D Valentine; Marc O Anderson; Feroz R Papa; Peter M Haggie
Journal:  PLoS Pathog       Date:  2013-08-22       Impact factor: 6.823

5.  N-(3-oxo-acyl) homoserine lactone inhibits tumor growth independent of Bcl-2 proteins.

Authors:  Guoping Zhao; Aaron M Neely; Christian Schwarzer; Huayi Lu; Aaron G Whitt; Nicole S Stivers; Joseph A Burlison; Carl White; Terry E Machen; Chi Li
Journal:  Oncotarget       Date:  2016-02-02

Review 6.  Intra-Species and Inter-Kingdom Signaling of Legionella pneumophila.

Authors:  Ramon Hochstrasser; Hubert Hilbi
Journal:  Front Microbiol       Date:  2017-02-03       Impact factor: 5.640

7.  Regulation and Molecular Mechanism of TLR5 on Resistance to Escherichia coli F18 in Weaned Piglets.

Authors:  Chaohui Dai; Li Yang; Jian Jin; Haifei Wang; Shenglong Wu; Wenbin Bao
Journal:  Animals (Basel)       Date:  2019-09-27       Impact factor: 2.752

8.  Immunoediting role for major vault protein in apoptotic signaling induced by bacterial N-acyl homoserine lactones.

Authors:  Josep Rayo; Rachel Gregor; Nicholas T Jacob; Rambabu Dandela; Luba Dubinsky; Alex Yashkin; Alexander Aranovich; Manikandan Thangaraj; Orna Ernst; Eran Barash; Sergey Malitsky; Bogdan I Florea; Bastiaan P Krom; Erik A C Wiemer; Valerie A Kickhoefer; Leonard H Rome; John C Mathison; Gunnar F Kaufmann; Herman S Overkleeft; Benjamin F Cravatt; Tsaffrir Zor; Kim D Janda; Richard J Ulevitch; Vladimir V Kravchenko; Michael M Meijler
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-23       Impact factor: 12.779

9.  Volatiles from Subtropical Convolvulaceae That Interfere with Bacterial Cell-to-Cell Communication as Potential Antipathogenic Drugs.

Authors:  María C Luciardi; María V Pérez Hernández; Nora Muruaga; Alicia Bardón; Mario E Arena; Elena Cartagena
Journal:  Evid Based Complement Alternat Med       Date:  2016-05-22       Impact factor: 2.629

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.